DE60109945D1 - IBUPROFEN-LöSUNGEN ALS KAPSELFüLLUNG UND KAPSEL-ZUBEREITUNGEN - Google Patents

IBUPROFEN-LöSUNGEN ALS KAPSELFüLLUNG UND KAPSEL-ZUBEREITUNGEN

Info

Publication number
DE60109945D1
DE60109945D1 DE60109945T DE60109945T DE60109945D1 DE 60109945 D1 DE60109945 D1 DE 60109945D1 DE 60109945 T DE60109945 T DE 60109945T DE 60109945 T DE60109945 T DE 60109945T DE 60109945 D1 DE60109945 D1 DE 60109945D1
Authority
DE
Germany
Prior art keywords
ibuprofen
capsule
preparations
agent
filling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60109945T
Other languages
English (en)
Other versions
DE60109945T2 (de
Inventor
Soichiro Kato
Katsuyuki Tsumori
Yasuo Shinoda
Toshio Inagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of DE60109945D1 publication Critical patent/DE60109945D1/de
Publication of DE60109945T2 publication Critical patent/DE60109945T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60109945T 2000-08-25 2001-08-23 IBUPROFEN-LöSUNGEN ALS KAPSELFüLLUNG UND KAPSEL-ZUBEREITUNGEN Expired - Lifetime DE60109945T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000255827 2000-08-25
JP2000255827 2000-08-25
PCT/JP2001/007223 WO2002015900A1 (fr) 2000-08-25 2001-08-23 Solutions d'ibuprofene destinees a etre mises en gelules et preparations en gelules

Publications (2)

Publication Number Publication Date
DE60109945D1 true DE60109945D1 (de) 2005-05-12
DE60109945T2 DE60109945T2 (de) 2006-04-27

Family

ID=18744550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60109945T Expired - Lifetime DE60109945T2 (de) 2000-08-25 2001-08-23 IBUPROFEN-LöSUNGEN ALS KAPSELFüLLUNG UND KAPSEL-ZUBEREITUNGEN

Country Status (14)

Country Link
US (1) US20030187070A1 (de)
EP (1) EP1321140B1 (de)
JP (1) JP3553562B2 (de)
KR (1) KR100762115B1 (de)
CN (1) CN1215837C (de)
AT (1) ATE292461T1 (de)
AU (1) AU2001280124A1 (de)
CA (1) CA2419147C (de)
DE (1) DE60109945T2 (de)
EA (1) EA005494B1 (de)
ES (1) ES2240492T3 (de)
PT (1) PT1321140E (de)
TW (1) TWI285115B (de)
WO (1) WO2002015900A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005206084A1 (en) * 2004-01-09 2005-08-04 Wyeth Microemulsions for pharmaceutical compositions
JP2005289905A (ja) * 2004-03-31 2005-10-20 Zeria Pharmaceut Co Ltd 医薬組成物
JP4710240B2 (ja) * 2004-03-31 2011-06-29 ゼリア新薬工業株式会社 医薬組成物
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US20070224261A1 (en) * 2006-03-22 2007-09-27 Peter Draper Eutectic liquid drug formulation
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
NZ602977A (en) 2010-04-15 2016-02-26 Chromocell Corp Compounds, compositions, and methods for reducing or eliminating bitter taste
MX355775B (es) 2011-10-20 2018-04-30 Chromocell Corp Compuestos, composiciones y metodos para reducir o eliminar el sabor amargo.
WO2016001643A1 (en) * 2014-06-30 2016-01-07 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
WO2016084099A1 (en) * 2014-11-25 2016-06-02 Biological E Limited Soft gelatin capsule composition of anti-tussive agents
EP3863603A1 (de) 2018-10-08 2021-08-18 Chanelle Pharmaceuticals Manufacturing Ltd. Weichgelkapselformulierung, verfahren zu ihrer herstellung und ihre verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US6525214B1 (en) * 1991-05-13 2003-02-25 Bernard John Armitage Therapeutic agent
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
JPH08509725A (ja) * 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
JPH08333246A (ja) * 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
WO1998002182A1 (en) * 1996-07-12 1998-01-22 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
US5914129A (en) * 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
CN1373674A (zh) * 1999-09-11 2002-10-09 宝洁公司 易流动液体载体

Also Published As

Publication number Publication date
KR20030068535A (ko) 2003-08-21
DE60109945T2 (de) 2006-04-27
CA2419147C (en) 2008-10-07
CA2419147A1 (en) 2003-02-10
ATE292461T1 (de) 2005-04-15
US20030187070A1 (en) 2003-10-02
EP1321140B1 (de) 2005-04-06
PT1321140E (pt) 2005-06-30
CN1471389A (zh) 2004-01-28
EP1321140A4 (de) 2004-01-21
AU2001280124A1 (en) 2002-03-04
EP1321140A1 (de) 2003-06-25
JPWO2002015900A1 (ja) 2004-06-10
WO2002015900A1 (fr) 2002-02-28
EA005494B1 (ru) 2005-02-24
CN1215837C (zh) 2005-08-24
EA200300292A1 (ru) 2003-10-30
TWI285115B (en) 2007-08-11
ES2240492T3 (es) 2005-10-16
JP3553562B2 (ja) 2004-08-11
KR100762115B1 (ko) 2007-10-04

Similar Documents

Publication Publication Date Title
ATE292461T1 (de) Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
DE69421918D1 (de) Hochdosierte arzneizusammensetzungen
DE60123384D1 (de) Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
SE0000773D0 (sv) New formulation
RS49703B (sr) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
ATE311858T1 (de) Dosierungsform mit flüssiger formulierung
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
ATE232741T1 (de) Pharmazeutische injizierbare lösungen, die paracetamol und kombinationen aus paracetamol mit anderen aktivsubstanzen enthalten
AR027554A1 (es) Nuevo sistema de adminstracion de farmacos autoemulsionante
PT1170003E (pt) Sistema de administracao de farmacos auto-emulsionante para
WO1995004528A3 (en) PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE
IT1307852B1 (it) Un dispositivo per la somministrazione per via transcutanea dimolecole contenute in un prodotto veicolante relativamente viscoso,
AR036304A1 (es) Sistema nuevo de liberacion de droga autoemulsionable
DE69710423D1 (de) Orale pharmazeutische Zubereitung mit antipyretischer, analgetischer und entzündungshemmender Wirkung.
BR0007473A (pt) Composições tendo estabilidade melhorada
AR034436A1 (es) Agentes terapeuticos.
IS6532A (is) Lyfjaform til stýrðrar losunar á síprófloxasíni með inntöku um munn einu sinni á dag
ES2051658T1 (es) Comprimido efervescente de facil administracion.
DE69729729D1 (de) Arzneimittel zur anwendung im mund
JPS5762220A (en) Embrocation for external use
UY26503A1 (es) " forma de dosificación de fármacos accionada por un hidrogel"
Maru et al. Formulation and evaluation of tenoxicam gels for tropical use
AR027555A1 (es) Nuevo sistema de administracion de farmacos emulsionante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition